carboplatin,cisplatin,datopotamab,datopotamab,pembrolizumab
daiichi sankyo,merck,astrazeneca
['pembro', 'tropion,lung02', 'lung', 'tropion,lung,02', 'lcsm,(-blcsm)', 'tropion,lung,2']
#asco2023 oral session: tropion-lung02: dato-dxd + pembr) with or without platinum ct dato-dxd +
pembro pt-ct demonstrated tolerable safety with notable 1l activity (rr 50% for doublet and 57% for triplet. #lcsm 
Associate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Head of Thoracic Oncology & Clinical Trials. Professor  @UAM_Madrid previously @RoyalFreeNHS London